Plexium Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 74
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $102M
Latest Deal Amount
  • Investors
  • 15

Plexium General Information

Description

Developer of protein degrading therapeutics intended to treat cancer and other serious diseases. The company's therapeutics aid to identify novel small molecules that redirect ligases to targets of interest or induce degradation of targets by directly binding to them, enabling the medical community to combat cancer and inflammatory diseases in an improved manner.

Contact Information

Website
www.plexium.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 11494 Sorrento Valley Road
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Plexium Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Plexium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 23-Feb-2022 $102M 00000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 21-Jan-2021 0000 0000 00000 Completed Generating Revenue
To view Plexium’s complete valuation and funding history, request access »

Plexium Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 000,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-1 10,764,643 $0.000100 $0.42 $0.42 1x $0.42 4.26%
Series A 38,253,579 $0.000100 $0.74 $0.74 1x $0.74 15.12%
To view Plexium’s complete cap table history, request access »

Plexium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of protein degrading therapeutics intended to treat cancer and other serious diseases. The company's therapeut
Drug Discovery
San Diego, CA
74 As of 2022
00000
0000 0000-00-00
0000000000 0 00000

00000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000 000000000
San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

000000 0

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000 000000000
Weston, FL
0 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Plexium Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FibroGen Formerly VC-backed San Francisco, CA 000 00000 000000 - 000 00000
000000 00000000000 Venture Capital-Backed Weston, FL 0 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Beijing, China 000 00000 00000000 00000
0000000 Venture Capital-Backed London, United Kingdom 0000 0000000000 0 0000
00000000 000000000 Formerly VC-backed Carmiel, Israel 000 00000 000000000 00000
You’re viewing 5 of 34 competitors. Get the full list »

Plexium Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Plexium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210269413-A1 Quinazolinone compounds and related compounds Pending 21-Feb-2020 0000000000
US-11027272-B1 Transfer dispensers for assay devices Active 28-Jan-2020 0000000000 0
US-11040343-B1 Caps for assay devices Active 28-Jan-2020 0000000000 0
US-20210229087-A1 Assay devices for combinatorial libraries Pending 28-Jan-2020 0000000000
US-20210308668-A1 Caps for assay devices Pending 28-Jan-2020 B01L3/5025
To view Plexium’s complete patent history, request access »

Plexium Executive Team (7)

Name Title Board Seat Contact Info
Percival Barretto-Ko Chief Executive Officer, Board of Director & President
Jennifer Cygan Ph.D Chief Business Officer
You’re viewing 2 of 7 executive team members. Get the full list »

Plexium Board Members (10)

Name Representing Role Since
Adam Goulburn Ph.D Lux Capital Board Member 000 0000
Cariad Chester Self Board Member 000 0000
Dylan Morris Ph.D CRV Board Observer 000 0000
Kiersten Stead Ph.D DCVC Bio Board Member 000 0000
Michael Grey Self Executive Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Plexium Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Plexium Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BVF Partners Hedge Fund Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
RA Capital Management Hedge Fund Minority 000 0000 000000 0
SoftBank Vision Fund 2 Venture Capital Minority 000 0000 000000 0
Surveyor Capital Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial